相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells
Theresa Hydes et al.
IMMUNITY INFLAMMATION AND DISEASE (2018)
T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System
Wei-Chen Huang et al.
JOURNAL OF IMMUNOLOGY (2017)
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection
Laura J. Pallett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival
Matteo Donadon et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
LIVER CANCER Translating '-omics' results into precision medicine for hepatocellular carcinoma
Daniela Sia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
Sam Sheppard et al.
NATURE COMMUNICATIONS (2017)
Induction of resident memory T cells enhances the efficacy of cancer vaccine
Mevyn Nizard et al.
NATURE COMMUNICATIONS (2017)
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
Thornton W. Thompson et al.
ELIFE (2017)
IL-15 signaling in NK cell cancer immunotherapy
Jai Rautela et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Hallmarks of Tissue-Resident Lymphocytes
Xiying Fan et al.
CELL (2016)
Role of Immunity in Pathogenesis and Treatment of Hepatocellular Carcinoma
Nathalie Schmidt et al.
DIGESTIVE DISEASES (2016)
Tissue-resident Eomeshi T-betlo CD56bright NK cells with reduced proinflammatory potential are enriched in the adult human liver
Cathal Harmon et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
Kelly Hudspeth et al.
JOURNAL OF AUTOIMMUNITY (2016)
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
Bai Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation
Antonia O. Cuff et al.
JOURNAL OF IMMUNOLOGY (2016)
NK cells and type 1 innate lymphoid cells: partners in host defense
Hergen Spits et al.
NATURE IMMUNOLOGY (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
Takahiro Kamiya et al.
CANCER IMMUNOLOGY RESEARCH (2016)
CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
Kerstin A. Stegmann et al.
SCIENTIFIC REPORTS (2016)
Emerging insights into natural killer cells in human peripheral tissues
Niklas K. Bjorkstrom et al.
NATURE REVIEWS IMMUNOLOGY (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
The emerging role of immunotherapy in colorectal cancer
David Lynch et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ
Yin Guo et al.
JOURNAL OF IMMUNOLOGY (2015)
CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
Faycal Djenidi et al.
JOURNAL OF IMMUNOLOGY (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo
Wen Jiang et al.
IMMUNOBIOLOGY (2014)
Cancer exosomes and NKG2D receptor-ligand interactions: Impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance
Lucia Mincheva-Nilsson et al.
SEMINARS IN CANCER BIOLOGY (2014)
Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence
Hiroteru Kamimura et al.
JOURNAL OF HEPATOLOGY (2012)
Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
Niels Halama et al.
CLINICAL CANCER RESEARCH (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
Lun Cai et al.
CLINICAL IMMUNOLOGY (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
S Gasser et al.
NATURE (2005)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
JD Coudert et al.
BLOOD (2005)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)